BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8869959)

  • 1. Clinical trials referral resource. Clinical trials in the CNS Consortia.
    Kaplan RS; Phillips PH; Cheson BD
    Oncology (Williston Park); 1996 Aug; 10(8):1183-4. PubMed ID: 8869959
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials referral resource. Current clinical trials in CNS tumors.
    Kaplan RS; Schoenfeldt M
    Oncology (Williston Park); 2004 Mar; 18(3):322, 327, 330 passim. PubMed ID: 15065702
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials referral resource. Primary central nervous system tumors.
    Cheson BD; Kaplan RS; Phillips PH
    Oncology (Williston Park); 1994 Oct; 8(10):51-2, 55. PubMed ID: 7803215
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials. Referral resource. Clinical trials assessing quality of life.
    Cheson BD; McCabe MS; Phillips PH
    Oncology (Williston Park); 1995 Nov; 9(11):1171-4, 1176, 1178. PubMed ID: 8703685
    [No Abstract]   [Full Text] [Related]  

  • 5. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors.
    Meyers CA; Brown PD
    J Clin Oncol; 2006 Mar; 24(8):1305-9. PubMed ID: 16525186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system germ cell tumors.
    Balmaceda C; Modak S; Finlay J
    Semin Oncol; 1998 Apr; 25(2):243-50. PubMed ID: 9562458
    [No Abstract]   [Full Text] [Related]  

  • 7. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
    Abrey LE; Batchelor TT; Ferreri AJ; Gospodarowicz M; Pulczynski EJ; Zucca E; Smith JR; Korfel A; Soussain C; DeAngelis LM; Neuwelt EA; O'Neill BP; Thiel E; Shenkier T; Graus F; van den Bent M; Seymour JF; Poortmans P; Armitage JO; Cavalli F;
    J Clin Oncol; 2005 Aug; 23(22):5034-43. PubMed ID: 15955902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
    Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system tumors.
    Packer RJ; MacDonald T; Vezina G
    Pediatr Clin North Am; 2008 Feb; 55(1):121-45, xi. PubMed ID: 18242318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric CNS tumors: current treatment and future directions.
    Hargrave DR; Zacharoulis S
    Expert Rev Neurother; 2007 Aug; 7(8):1029-42. PubMed ID: 17678498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge.
    Stemmler HJ; Heinemann V
    Oncologist; 2008 Jul; 13(7):739-50. PubMed ID: 18614587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of patients with primary central nervous system (CNS) germinoma: current controversies requiring resolution.
    Finlay J; da Silva NS; Lavey R; Bouffet E; Kellie SJ; Shaw E; Saran F; Matsutani M
    Pediatr Blood Cancer; 2008 Aug; 51(2):313-6. PubMed ID: 18421722
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary CNS lymphoma: is there a role for prophylaxis against lymphomatous meningitis?
    DeAngelis L; Batchelor T
    Expert Rev Neurother; 2004 Jul; 4(4 Suppl):S19-24. PubMed ID: 15853551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting the improved outcome of patients with central nervous system metastases managed in clinical trials compared with standard hospital practice.
    Tang JI; Back M; Shakespeare T; Lu JJ; Mukherjee R; Wynne C; Liang S
    Australas Radiol; 2005 Oct; 49(5):390-5. PubMed ID: 16174177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials referral resource. Current clinical trials of thalidomide.
    Streicher HZ; Vereshchagina LA; Schoenfeldt M
    Oncology (Williston Park); 2003 Mar; 17(3):369-71, 374-5, 379-80. PubMed ID: 12661268
    [No Abstract]   [Full Text] [Related]  

  • 18. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
    Gonzalez-Angulo AM; Cristofanilli M; Strom EA; Buzdar AU; Kau SW; Broglio KR; Smith TL; Hortobagyi GN
    Cancer; 2004 Oct; 101(8):1760-6. PubMed ID: 15386311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials referral resource. Current clinical trials in mesothelioma.
    Saxman S; Schoenfeldt M
    Oncology (Williston Park); 2004 Sep; 18(10):1280, 1283, 1285. PubMed ID: 15526831
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials referral resource. Current clinical trials in rhabdomyosarcoma.
    Anderson BD; Schoenfeldt M
    Oncology (Williston Park); 2005 Sep; 19(10):1319-20, 1330. PubMed ID: 16285226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.